Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: A preliminary report

2003 ◽  
Vol 33 (2) ◽  
pp. 172-177 ◽  
Author(s):  
Giovanni B. Cassano ◽  
Mario Miniati ◽  
Stefano Pini ◽  
Alessandro Rotondo ◽  
Susanna Banti ◽  
...  
2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Daniela Mercado ◽  
Ulrike Schmidt ◽  
Owen G. O’Daly ◽  
Iain C. Campbell ◽  
Jessica Werthmann

AbstractTreatment outcomes in anorexia nervosa (AN) remain suboptimal, evidencing the need for better and more targeted treatments. Whilst the aetiology of AN is complex, cognitive processes such as attention bias (AB) have been proposed to contribute to maintaining food restriction behaviour. Attention bias modification raining (ABMT) has been investigated in other eating disorders (EDs) such as binge eating disorder (BED) as a means of modifying AB for food and of changing eating behaviour. Promising findings have been reported, but the mechanisms underlying ABMT are poorly understood. We hypothesise that in AN, ABMT has the potential to modify maladaptive eating behaviours related to anxiety around food and eating and propose two mechanistic models; (1) ABMT increases general attentional control (which will improve control over disorder-relevant thoughts) or (2) ABMT promotes stimulus re-evaluation. In this second case, the effects of ABMT might arise via changes in the subjective value of food stimuli (i.e. reward processing) or via habituation, with both resulting in a reduced threat response. Investigating the clinical potential of ABMT in AN holds the promise of a novel, evidence-based adjunctive treatment approach. Importantly, understanding ABMT’s underlying mechanisms will help tailor treatment protocols and improve understanding of the cognitive characteristics of AN and other EDs.


Author(s):  
Adar Avnon ◽  
Naomi Orkaby ◽  
Arik Hadas ◽  
Uri Berger ◽  
Anat Brunstein Klomek ◽  
...  

1987 ◽  
Vol 60 (2) ◽  
pp. 511-518 ◽  
Author(s):  
Lori A. Goldfarb ◽  
Robert Fuhr ◽  
Richard N. Tsujimoto ◽  
Stanley E. Fischman

This preliminary work assessed the effectiveness of systematic desensitization and relaxation training as adjuncts in the treatment of anorexia nervosa. All subjects (18 female anorexics) received behavioral contracting and supportive psychotherapy from the same psychiatrist. Seven were randomly assigned to receive either desensitization ( n = 4) or relaxation training ( n = 3) as an adjunctive treatment. Data on the 11 subjects without adjunctive treatment came from closed case files. Contrary to prediction, all significant differences in outcome favored use of relaxation. Relaxation was associated with higher self-esteem and less fear of fat than desensitization was at the 6-mo. follow-up and relaxation was associated with much better outcome at 18 mo. than were desensitization or no adjunctive treatment. Anorexia appears to differ from classical phobias in two ways, which may explain the unexpected effectiveness of relaxation training.


2018 ◽  
Vol 8 (3) ◽  
pp. 127-137 ◽  
Author(s):  
Marketa Marvanova ◽  
Kirstin Gramith

Abstract Introduction: Anorexia nervosa (AN) is a severe psychiatric disorder that is difficult to treat and is associated with frequent relapses and high mortality rates. Psychiatric symptomatology (eg, depression, anxiety, obsessive-compulsive disorder/behaviors) are common comorbidities. This review provides current information about safety and efficacy of antidepressant therapy for management of AN in adults. Methods: A literature review of randomized controlled trials, open-label studies, and case reports with adults or adults/adolescents was conducted. PubMed and Medline were searched using anorexia management and treatment, antidepressants, selective serotonin reuptake inhibitors (SSRIs), fluoxetine, sertraline, citalopram, and mirtazapine in AN, relapse prevention in AN, and psychotropic medications in AN. Results: The role and utility of antidepressants in AN were published in double-blind, placebo-controlled studies; open-label trials; and a retrospective study. Antidepressants should not be used as sole therapy for AN although their use for confounding symptomatology makes discerning efficacy difficult as they are given together with other therapies. Neurobiological changes due to starvation and AN itself complicate results interpretation. For safety, tricyclic antidepressants and monoamine oxidase inhibitors are not recommended, and bupropion is contraindicated. Use of SSRIs during acute treatment lacks efficacy. Use of SSRIs—primarily fluoxetine and to some extent citalopram, sertraline, or mirtazapine—may aid in relapse prevention and improvement of psychiatric symptomatology in weight-restored anorexic patients. Discussion: Health care professionals should use clinical judgment regarding fluoxetine or possibly citalopram, sertraline or mirtazapine as adjunctive treatment to psychotherapy for relapse prevention, improvement of depressive and anxiety symptoms, and/or obsessive-compulsive behaviors unresolved with nutritional rehabilitation and psychotherapy.


2013 ◽  
Vol 147 (1-3) ◽  
pp. 407-410 ◽  
Author(s):  
Linda C. Schaffer ◽  
Charles B. Schaffer ◽  
Amber R. Miller ◽  
Jillian L. Manley ◽  
Jennifer A. Piekut ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document